drugset / Trial / NCT00869141

Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma

NCT00869141

Phase 4 Completed 52 enrolled University of California, Los Angeles
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the occurrence rate of the high pressure phase and the final pressure outcomes between patients treated with glaucoma medication prior to the expected onset of the high pressure phase to those patients who have glaucoma medication started at the onset of the high pressure phase. The investigators hypothesize that if glaucoma medications are started prior to the expected onset of high pressure phase, the high pressure phase will not occur as frequently and the ultimate pressure level will be lower than if the glaucoma medications are started at the onset of this phase.

Timeline

Start
2009-03
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule
Subject Brinzolamide Small molecule
Subject Dorzolamide Small molecule
Subject Timolol Other / unclassified

Indications